Zahra Talattof
Department of Oral Medicine, School of Dentistry, Shiraz University of Medical Sciences, Shiraz, Iran
Azita Azad
Department of Oral Medicine, School of Dentistry, Shiraz University of Medical Sciences, Shiraz, Iran
ABSTRACT
While adverse drug reaction (ADR) reporting card (yellow card) system has started in 1998 in Iran, the ADR reporting rate was very low. To explore if the Iranian adverse drug reaction reporting system could be modified and to determine causes of under-reporting among dentists, a study to investigate the role of dentists in ADR reporting was done in marvdasht city (Fars province, south of Iran). A cross-sectional study was done between February and December 2014 in marvdasht city, Iran. After describing the study and its aims for each dentist, oral consent was taken. A number of 40 out of 50 dentists (80%) agreed to participate in the interview. All respondents were working in private dental clinic. Although level of knowledge regarding ADR was low among dentists, all of them admitted that paying attention to ADRs and timely reporting is very important. About ADR in the university, 10% believed that it was enough, 70% claimed that it was not satisfactory and 20% admitted that it was little. It is concluded that Our dentists have little knowledge about the process, goal and importance of ADR reporting system. Otherwise, education and training will be important in maintaining and enhancing ADR reports by dentists.
PDF References
How to cite this article
Zahra Talattof and Azita Azad, 2015. An Evaluation of Knowledge, Attitude and Practice of Adverse Drug Reaction Reporting in Dental Practice. Pakistan Journal of Nutrition, 14: 712-715.
DOI: 10.3923/pjn.2015.712.715
URL: https://scialert.net/abstract/?doi=pjn.2015.712.715
DOI: 10.3923/pjn.2015.712.715
URL: https://scialert.net/abstract/?doi=pjn.2015.712.715
REFERENCES
- Boyd, I.W., 2002. The role of the Australian Adverse Drug Reactions Advisory Committee (ADRAC) in monitoring drug safety. Toxicology, 181-182: 99-102.
CrossRefDirect Link - Du, W., J.J. Guo, Y. Jing, X. Li and C.M.L. Kelton, 2008. Drug safety surveillance in China and other countries: A review and comparison. Value Health, 11: S130-S136.
CrossRefDirect Link - Green, C.F., D.R. Mottram, P.H. Rowe and M. Pirmohamed, 2001. Attitudes and knowledge of hospital pharmacists to adverse drug reaction reporting. Br. J. Clin. Pharmacol., 51: 81-86.
CrossRefDirect Link - Hajebi, G., S.A. Mortazavi, J. Salamzadeh and A. Zian, 2010. A survey of knowledge, attitude and practice of nurses towards pharamacovigilance in Taleqani hospital. Iranian J. Pharm. Res., 9: 199-206.
Direct Link - Johnson, J.A. and J.L. Bootman, 1995. Drug-related morbidity and mortality: A cost-of-illness model. Arch. Intern. Med., 155: 1949-1956.
CrossRefDirect Link - Lacoste-Roussillon, C., P. Pouyanne, F. Haramburu, G. Miremont and B. Begaud, 2001. Incidence of serious adverse drug reactions in general practice: A prospective study. Clin. Pharmacol. Therapeut., 69: 458-462.
CrossRefDirect Link - Li, Q., S.M. Zhang, H.T. Chen, S.P. Fang and X. Yu et al., 2004. Awareness and attitudes of healthcare professionals in Wuhan, China to the reporting of adverse drug reactions. Chinese Med. J., 117: 856-861.
PubMedDirect Link - Rawlins, M.D., 1995. Pharmacovigilance: Paradise lost, regained or postponed? The William Withering Lecture 1994. J. Royal Coll. Phys. London, 29: 41-49.
Direct Link - Scott, H.D., A. Thacher-Renshaw, S.E. Rosenbaum, W.J. Waters, Jr., M. Green, L.G. Andrews and G.A. Faich, 1990. Physician reporting of adverse drug reactions: Results of the rhode island adverse drug reaction reporting project. J. Am. Med. Assoc., 263: 1785-1788.
CrossRefDirect Link - Su, C., H. Ji and Y. Su, 2010. Hospital pharmacists' knowledge and opinions regarding adverse drug reaction reporting in Northern China. Pharmacoepidemiol. Drug Saf., 19: 217-222.
CrossRefDirect Link - Sohrevardi, S.M. and M.R. Heidari, 2009. Kerman health system workers knowledge and attitudes regarding the spontaneous reporting system for adverse drug reactions. Iranian J. Pharm. Sci., 5: 249-252.
Direct Link - Toklu, H.Z. and M.K. Uysal, 2008. The knowledge and attitude of the Turkish community pharmacists toward pharmacovigilance in the Kadikoy district of Istanbul. Pharm. World Sci., 30: 556-562.
CrossRefDirect Link - Vora, M.B., H.R. Trivedi, B.K. Shah and C.B. Tripathi, 2011. Adverse drug reactions in inpatients of internal medicine wards at a tertiary care hospital: A prospective cohort study. J. Pharm. Pharmacother., 2: 21-25.
CrossRefDirect Link - Vessal, G., Z. Mardani and M. Mollai, 2009. Knowledge, attitudes and perceptions of pharmacists to adverse drug reaction reporting in Iran. Pharm. World Sci., 31: 183-187.
CrossRefPubMedDirect Link - Pirmohamed, M., K.N. Atuah, A.N.O. Dodoo and P. Winstanley, 2007. Pharmacovigilance in developing countries. Br. Med. J., Vol. 335.
CrossRefDirect Link